Catherine Wainwright is the Senior Director of New Product Introduction and Programme Management, responsible for product development and technical projects at Cycle. Dr Wainwright joined Cycle in 2014 and since this time has supported the development of NITYR® (nitisinone) Tablets and Cycle’s generics portfolio. She is currently managing the development of Cycle’s rapidly expanding pipeline as well as the continuous improvement of Cycle’s approved products.
Prior to joining Cycle, Dr Wainwright worked in API process development and small scale manufacturing. She holds a BSc in Medicinal Chemistry from The Queen’s University of Belfast and a PhD in Chemistry from Newcastle University and has spent time as a post-doctoral research assistant in academia in the US.
Global Regulatory Affairs and Clinical Development
Claudia Percivalle, Head of Global Regulatory Affairs and Clinical Development, oversees product lifecycle maintenance, regulatory strategy and new registrations, clinical and pharmacovigilance activities. Dr Percivalle joined Cycle in 2015 as Regulatory Affairs Manager and progressed to different roles, being appointed as head of the Regulatory Department in April 2019. Her contribution was critical to the approval of NITYR® (nitisinone) Tablets in several markets, including the U.S., the E.U. and Canada, as well as to the approval of the generic products Ketorolac Tromethamine tablets and injection.
Prior to joining Cycle, Dr Percivalle worked in prestigious academic institutions in the United Kingdom, including the Medical Research Council (Laboratory of Molecular Biology) in Cambridge and Imperial College London. She holds a MSci and a PhD in Chemistry and during her academic career she authored several publications in international peer reviewed journals.
Sonya Gade is the Director of Supply Chain, responsible for all aspects of the commercial supply chain for North America, MENA, Europe and Australia, management of contract manufacturing organisations, commercial and clinical packaging vendors and logistics partners.
Ms. Gade joined Cycle Pharmaceuticals in 2016 as a Project Manager, supporting the approval of generics and the launch of Nitisinone Tablets in Canada. She moved to support the commercial supply chain in 2018, becoming the Director of Supply Chain in April 2020.
Ms. Gade has worked within the Pharmaceutical industry for 15 years. With extensive experience within Drug Metabolism and Pharmacokinetics with LGC and GlaxoSmithKline.
Nicki Giles is Head of Finance overseeing Cycle’s finance and accounts.
Ms Giles has more than 30 years’ accountancy experience in the banking, service and technology sectors. Ms Giles has previously worked in a variety of companies that range in size from large plcs to smaller start-ups including Plasmon Plc and Light Blue Optics.
Alice Clarkson is Head of Legal (Global) overseeing Cycle’s commercial legal function. Ms Clarkson joined Cycle in 2018 as Legal Counsel, supporting the General Counsel in all legal matters, before taking on more responsibility in 2020, and leadership of the commercial legal function in 2021.
Prior to joining Cycle, Ms Clarkson was in-house Legal Counsel at the semiconductor and software design company, Arm Limited, holding various positions on senior leadership teams. She holds an LLB (Hons) in Law from the Queen’s University of Belfast, a PGDip in Legal Practice from the Oxford Institute of Legal Practice, an MBA from Anglia Ruskin University and a Level 7 Diploma in Strategic Management & Leadership Practice from the Chartered Management Institute.
Romina Briffa is an experienced quality assurance professional with expertise and training in pharmacy, higher education, and the pharmaceutical industry. A pharmacist by training, Dr. Briffa obtained her Master of Science specialized in industrial pharmacy and is experienced in GDP and GMP quality management systems. In her previous managerial roles, she worked with big pharma as well as generic and orphan drugs companies. She obtained her PhD in Molecular and Clinical Medicine from the University of Edinburgh and consolidated her interest in theranostics with post-doctoral training at the University of St Andrews and the University of Malta. Romina has a special interest in colorectal cancer molecular pathology, molecular and cellular biology, and translational research.
Chris Shaw is Cycle’s Head of HR with responsibility for leading the future of work strategy across the business. With over 15 years of experience in HR ranging from Fortune 500 companies to AIM listed SMEs, Mr Shaw has worked across multiple industries and brings considerable experience in HR strategic planning and execution, change management, and talent and leadership development.
Mr Shaw joined Cycle in May 2021 and is driven by the desire to deliver commercial success within industry-leading work environments that promote innovation, engagement and a continuous culture of growth and development.
Naomi joined the Cycle team in December 2021 as US Brand Manager. Naomi has worked in a variety of B2B manufacturing industries from AV, Flooring, Lighting and Plastic drainage!
After 8 years of starting her career as a receptionist/administrator Naomi decided to focus on a future in marketing, she has now been working in the marketing industry for 15 years. Starting off as a marketing assistant for an AV company working in the education sector she soon moved into a marketing executive role for Tarkett, an international flooring company, this was the start of her international marketing career.
As she started to climb the career ladder she secured a role as marketing communications manager for Helvar, a Finnish lighting company. This role saw her not just working from the UK but travelling around Europe being a frequent visitor to Head Office based in Helsinki. Due changes within the business her role was made redundant and she became International Marketing Manager at Polypipe.
In 2016 Naomi gained her Certificate in Marketing (CIM/CAM) enabling her to strengthen her marketing knowledge and experience, bringing this to the marketing team at Cycle.
Prior to Cycle Matt has worked for various companies in varied industries including Pharma, Life Sciences, Manufacturing, and Financial Services all in accountancy roles predominantly in FP&A and business partnering capacity, Matt Graduated from Durham university with a BA in Business Finance.
Erum Haq is Cycle’s Supply Chain Director and is responsible for all aspects of the commercial supply chain across all global markets. This includes the management of contract manufacturing partners, commercial and clinical packaging vendors and logistics partners.
Ms Haq joined Cycle in 2020 from Roche Pharmaceuticals where she held the position of Head of Supply Chain across their commercial and clinical portfolios. Prior to that Ms Haq held a variety of different Supply Chain Management roles for GlaxoSmithKline, as well as the positions of Business Development Manager at DHL, Clinical Trials Manager at IQVIA and Head of Quality at the UCL Clinical Research Centre. Ms Haq has gained her professional experiences at an international level, having worked in both the UK and Australia.
Ms Haq has broad experience and a strong passion for supply chain and a consistent track record for coaching and people development. She is a registered pharmacist in the UK and Australia, holds an Executive MBA from the Imperial College London, is a Certified Supply Chain Professional and a Lean Six Sigma Green Belt.
John Reid is Cycle’s Director of Patient Support. He is responsible for Cycle Vita, Cycle’s Patient Support Platform. During his time at Cycle Pharma, he has built Cycle Vita from the ground up leveraging nearly 20 years of Patient Services experience and paying close attention to every detail from the construction of the CRM to the hiring of the staff and definition of all the processes that drive Cycle Vita to provide the highest level of quality and support possible- because Every Single Patient Matters.
Prior to joining Cycle, John held critical roles across two industries with responsibility for Specialty Pharmacy Contracting, Vendor Management, Finance, Sales, and Customer Service. He is proud to use his MBA from Purdue University as a strong foundation of knowledge to bring better products and services to the rare and genetic disease space.
Zac Bohlen is Vice President, Head of Sales, US, overseeing and leading sales for all of Cycle’s branded products in the US. Mr Bohlen joined Cycle in January 2020 as Head of Operations. Mr Bohlen is an executive commercial leader with over 20 years of success in biotech, pharmaceuticals, specialty pharmacy and 503B outsourcing. He has progressed through roles of increasing responsibility in sales and marketing leadership, market access, business development and general management. Mr Bohlen has deep experience creating winning teams through positive coaching, maintaining accountability and leveraging his entrepreneurial mindset.
Prior to joining Cycle, Mr Bohlen worked in commercial roles for multiple life science companies that include Teva Pharmaceuticals, GlaxoSmithKline, Sanofi Aventis, AllCare Plus Pharmacy and RXQ Compounding.
Damien Sango is Cycle’s Manager of U.S. Market Access and Distribution. Damien oversees the development and implementation of Cycle’s U.S. Market Access and Distribution strategy for existing and new products, as well as Cycle’s relationships with the relevant industry partners.
Damien joined Cycle in 2019 as a member of the Regulatory Affairs team, supporting the global rollout and launch of Nityr in Rest of World markets before moving into business focused roles in 2020, supporting the asset evaluation of Cycle’s Branded Generic portfolio.
Prior to joining Cycle, Damien worked in Regulatory Affairs and R&D Manufacturing for CSL Behring.
Damien received his MBA from Melbourne Business School at the University of Melbourne in Australia.
Victoria Dickinson is Cycle’s US Brand and Product Launch Manager, responsible for product launch planning and execution in the US market, encompassing commercial readiness and supply. Ms. Dickinson also leads the development and implementation of US brand strategy.
Ms. Dickinson has 10 years’ experience in commercial marketing and communications, strategic and tactical. Prior to Cycle, she held roles in science, healthcare and technology specialist marketing agencies as well as public sector communications.
Ms. Dickinson holds an BSc (Hons) in Zoology from the University of Manchester.
Noah Sachs is US Legal Counsel based in Boston. Noah is an attorney with a specialty as in-house counsel for biotech, pharmaceutical, and technology companies. Previous clients have included Eisai Inc., Ediatas Medicine Inc., Takeda Pharmaceuticals, the Massachusetts Executive Office of Health and Human Services, Partners Healthcare, Philips Healthcare, and Lahey Hospital & Medical Center.
Mr Sachs is also a registered Patent Attorney and has a degree in molecular biology from The Evergreen State College. Prior to becoming an attorney, he worked as an associate scientist performing biotech and pharmaceutical research; his research included extensive work with laboratory robotics; he worked as a genetic engineer and can clone a gene from one organism to another.